UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 124

Sortiert nach

Association between Dictyocaulus viviparus status and milk production parameters in Dutch dairy herds

Journal of dairy science, 2015-11, Vol.98 (11), p.7741-7747

2015

Volltextzugriff (PDF)

Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction

Annals of oncology, 2008-08, Vol.19 (8), p.1450-1457

2008

Volltextzugriff (PDF)

FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study

Annals of oncology, 2013-07, Vol.24 (7), p.1769-1777

2013

Volltextzugriff (PDF)

Comparison of immunophenotypes of primary breast carcinomas and multiple corresponding distant metastases: an autopsy study of 25 patients

Clinical & experimental metastasis, 2017, Vol.34 (1), p.103-113

2017

Volltextzugriff (PDF)

1800 Final results for overall survival (OS), the primary endpoint of the CECOG TURANDOT prospective randomised trial evaluating bevacizumab-paclitaxel (BEV-PAC) vs BEV-capecitabine (CAP) for HER2-negative locally recurrent/metastatic breast cancer (LR/mBC)

European journal of cancer (1990), 2015-09, Vol.51, p.S263-S264

2015

Volltextzugriff (PDF)

A Retrospective Analysis of the First 41 mCRPC Patients with Bone Pain Treated with Radium-223 at the National Institute of Oncology in Hungary

Pathology oncology research, 2017-10, Vol.23 (4), p.777-783

2017

Volltextzugriff (PDF)

Vitamin D-neutralizing CYP24A1 expression, oncogenic mutation states and histological findings of human papillary thyroid cancer

Journal of endocrinological investigation, 2015-03, Vol.38 (3), p.313-321

2015

Volltextzugriff (PDF)

Vitamin D-neutralizing CYP24A1 expression, oncogenic mutation states and histological findings of human papillary thyroid cancer

Journal of endocrinological investigation, 2015-03, Vol.38 (3), p.313-321

2015

Volltextzugriff (PDF)

CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer

Journal of clinical oncology, 2015-05, Vol.33 (14), p.1564-1573

2015

Volltextzugriff (PDF)

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

The lancet oncology, 2013-05, Vol.14 (6), p.490-499

2013

Volltextzugriff (PDF)

1438 POSTER Claudin-4/E-cadherin Index to Predict Prognosis in Breast Cancer

European journal of cancer (1990), 2011, Vol.47, p.S181-S181

2011

Volltextzugriff (PDF)

Primary systemic therapy in breast cancer--an update for gynecologic oncologists

European journal of gynaecological oncology, 2011, Vol.32 (6), p.636-641

2011

Volltextzugriff (PDF)

Phase III Study of Letrozole Versus Tamoxifen as First-Line Therapy of Advanced Breast Cancer in Postmenopausal Women: Analysis of Survival and Update of Efficacy From the International Letrozole Breast Cancer Group

Journal of clinical oncology, 2003-06, Vol.21 (11), p.2101-2109

2003

Volltextzugriff (PDF)

Role of chemotherapy for advanced/recurrent gastric cancer: An individual-patient-data meta-analysis

European journal of cancer (1990), 2013-05, Vol.49 (7), p.1565-1577

2013

Volltextzugriff (PDF)

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial

The lancet oncology, 2013-02, Vol.14 (2), p.125-133

2013

Volltextzugriff (PDF)

A randomized, double-blind study of PF-05280014 (a potential biosimilar) vs trastuzumab, both given with docetaxel (D) and carboplatin (C), as neoadjuvant treatment for operable human epidermal growth factor receptor 2-positive (HER2+) breast cancer

Annals of oncology, 2017-09, Vol.28, p.v45-v45

2017

Volltextzugriff (PDF)

Real-world effectiveness and safety of first-line bevacizumab (BEV) + paclitaxel (PAC) in >2000 patients (pts) with HER2-negative metastatic breast cancer (mBC)

Annals of oncology, 2016-10, Vol.27, p.vi73-vi73

2016

Volltextzugriff (PDF)

Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group

Journal of clinical oncology, 2001-05, Vol.19 (10), p.2596-2606

2001

Volltextzugriff (PDF)

Demographic Characteristics and Treatment Patterns Among Patients Receiving Palbociclib for HR+/HER2- Advanced Breast Cancer: A Nationwide Real-World Experience

OncoTargets and therapy, 2021-01, Vol.14, p.3971-3981

2021

Volltextzugriff (PDF)

Deconstructing Immune Cell Infiltration in Human Colorectal Cancer: A Systematic Spatiotemporal Evaluation

Genes, 2022-03, Vol.13 (4), p.589

2022

Volltextzugriff (PDF)

Out of the Campus Closet: Student Professor Consensual Sexual Relationships: Paul R. Abramson: Romance in the Ivory Tower: The Rights and Liberty of Conscience, MIT Press, 2007, 176 pp

Sexuality & culture, 2008-09, Vol.12 (3), p.192-192

Dank, Barry M.

2008

Volltextzugriff (PDF)

Real World Evidence In Europe - The Results Of An Expert Survey

Value in health, 2017-10, Vol.20 (9), p.A655

2017

Volltextzugriff (PDF)

PHP21 - Real World Evidence In Europe - The Results Of An Expert Survey

Value in health, 2017-10, Vol.20 (9), p.A655-A655

2017

Volltextzugriff (PDF)

Out of the Campus Closet: Student Professor Consensual Sexual Relationships: Paul R. Abramson: Romance in the Ivory Tower: The Rights and Liberty of Conscience, MIT Press, 2007, 176 pp

Sexuality & Culture, 2008-03, Vol.12 (1), p.61-67

Dank, Barry M.

2008

Volltextzugriff (PDF)

Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer

Annals of oncology, 2004-10, Vol.15 (10), p.1527-1534

2004

Volltextzugriff (PDF)

1 – 25 von 124

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(102)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(59)
Life Sciences & Biomedicine
(53)
Humans
(39)
Female
(38)
Male
(31)
Oncology
(21)
Animals
(19)
Biological And Medical Sciences
(17)
Aged
(15)
Middle Aged
(15)
Treatment Outcome
(15)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)
Medical Sciences
(14)
Adult
(13)
Chemotherapy
(11)
Social Sciences
(11)
Veterinary Sciences
(11)
Breast Neoplasms - Drug Therapy
(10)
Retrospective Studies
(10)
Adolescent
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Association between Dictyocaulus viviparus status and milk production parameters in Dutch dairy herds

Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction

FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study

Comparison of immunophenotypes of primary breast carcinomas and multiple corresponding distant metastases: an autopsy study of 25 patients

1800 Final results for overall survival (OS), the primary endpoint of the CECOG TURANDOT prospective randomised trial evaluating bevacizumab-paclitaxel (BEV-PAC) vs BEV-capecitabine (CAP) for HER2-negative locally recurrent/metastatic breast cancer (LR/mBC)

A Retrospective Analysis of the First 41 mCRPC Patients with Bone Pain Treated with Radium-223 at the National Institute of Oncology in Hungary

Vitamin D-neutralizing CYP24A1 expression, oncogenic mutation states and histological findings of human papillary thyroid cancer

Vitamin D-neutralizing CYP24A1 expression, oncogenic mutation states and histological findings of human papillary thyroid cancer

CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

1438 POSTER Claudin-4/E-cadherin Index to Predict Prognosis in Breast Cancer

Primary systemic therapy in breast cancer--an update for gynecologic oncologists

Phase III Study of Letrozole Versus Tamoxifen as First-Line Therapy of Advanced Breast Cancer in Postmenopausal Women: Analysis of Survival and Update of Efficacy From the International Letrozole Breast Cancer Group

Role of chemotherapy for advanced/recurrent gastric cancer: An individual-patient-data meta-analysis

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial

A randomized, double-blind study of PF-05280014 (a potential biosimilar) vs trastuzumab, both given with docetaxel (D) and carboplatin (C), as neoadjuvant treatment for operable human epidermal growth factor receptor 2-positive (HER2+) breast cancer

Real-world effectiveness and safety of first-line bevacizumab (BEV) + paclitaxel (PAC) in >2000 patients (pts) with HER2-negative metastatic breast cancer (mBC)

Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group

Demographic Characteristics and Treatment Patterns Among Patients Receiving Palbociclib for HR+/HER2- Advanced Breast Cancer: A Nationwide Real-World Experience

Deconstructing Immune Cell Infiltration in Human Colorectal Cancer: A Systematic Spatiotemporal Evaluation

Out of the Campus Closet: Student Professor Consensual Sexual Relationships: Paul R. Abramson: Romance in the Ivory Tower: The Rights and Liberty of Conscience, MIT Press, 2007, 176 pp

Real World Evidence In Europe - The Results Of An Expert Survey

PHP21 - Real World Evidence In Europe - The Results Of An Expert Survey

Out of the Campus Closet: Student Professor Consensual Sexual Relationships: Paul R. Abramson: Romance in the Ivory Tower: The Rights and Liberty of Conscience, MIT Press, 2007, 176 pp

Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer

Suchergebnisse filtern